MedTrace Logo

A Comparison of Three Nebulizers for Standard Clinical and Research Use in Methacholine Challenge Testing

NCT02822859 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-10-26

No results posted yet for this study

Summary

The study will assess three different nebulizers for use in methacholine challenge testing in order to determine if the Aeroneb Solo would make a suitable replacement for the long-used and now obsolete Wright and Bennett-Twin nebulizers. Results from each device will be compared to evaluate whether current guidelines for the methacholine challenge should be updated for superior standardization.

Conditions

Interventions

DEVICE

Wright nebulizer

Roxon Medi-Tech, Montreal, QC, Canada

DEVICE

Bennett-Twin nebulizer

Puritan Bennett Corp., Carlsbad, CA, USA

DEVICE

Aeroneb Solo

Aerogen Ltd., Galway, Ireland

Sponsors & Collaborators

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Don Cockcroft, MD · University of Saskatchewan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02822859 on ClinicalTrials.gov